Xeris Pharmaceuticals | XERS - Stammkapital





Stammkapital Veränderung Datum
Celltrion KRW 229.65M 11.03M 2026-03
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Divis Laboratories Ltd INR 265.47M 0 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Kangmei Pharma CNY 13.83B 0 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Nektar Therapeutics USD 20.38M 20.36M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 136.47M 1.34M 2026-03
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 138.1M 500K 2026-03
Pharma Mar EUR 17.36M 0 2026-03
Qiagen NV USD 206.25M 10.31M 2026-03
Sartorius EUR 69.05M 0 2026-06
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
Tilray USD 116.52M 5.01M 2025-09
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03